<DOC>
	<DOCNO>NCT01145183</DOCNO>
	<brief_summary>Doxazosin , alpha 1-adrenergic receptor antagonist , may play important role cocaine addiction human . This study evaluate extent prospective screening catecholamine relate polymorphism alpha 1 NE receptor/transporter , COMT DBH main target predict treatment efficacy doxazosin cocaine-using behavior .</brief_summary>
	<brief_title>Pharmacogenetics Doxazosin Cocaine Dependence</brief_title>
	<detailed_description>The NE system , especially alpha 1-adrenergic receptor , may play important role cocaine addiction human . The result study provide medical safety data duration induction schedule optimal attain target dose 8 mg doxazosin daily guide future pharmacotherapy trial use Doxazosin relate alpha 1 receptor antagonist cocaine addiction . This 16-week double-blind , placebo control clinical trial provide treatment 100 cocaine-dependent patient include 13 week medication trial ( week 1-13 ) 2 week washout period ( week 14-15 ) . Qualifying subject randomize receive Doxazosin 8 mg/day , placebo study participation . Subjects receive 1 mg study medication/placebo capsule week 1 , 4mg/week induction rate week , accord randomized assignment , maintain agent week 13 . At end study ( week 14-15 ) , participant undergo discontinuation active/placebo medication 2-week period . Subjects wish transfer appropriate treatment program treatment-research program help referral 2 week period ( week 14-15 ) .</detailed_description>
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Doxazosin</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<criteria>( 1 ) Signed informed consent form ( 2 ) Subject understand risk benefit agree visit frequency procedure ( 3 ) Male female ( 4 ) Any race ethnic origin ( 5 ) Diagnosis cocainedependence accord DSMIV criterion ( 6 ) age 18 64 ( 7 ) Must current user cocaine selfreported use cocaine least weekly least one month precede study entry , cocainepositive urine screen score 3 cutoff diagnosis cocaine dependence assess Severity Dependence Scale ( Kaye &amp; Darke 2002 ; Gossop , et al 1995 ; Gossop , et al . 1997 ) ( 8 ) Women childbearing age eligible include study negative pregnancy test screening , agree adequate contraception prevent pregnancy , monthly pregnancy test , understand risk fetal toxicity due medication . ( 1 ) Current diagnosis drug , especially alcohol benzodiazepine dependence abuse ( cocaine tobacco ) ( 2 ) Significant medical condition ( e.g. , major cardiovascular , renal , endocrine , hepatic disorder ) abnormal liver function ( laboratory finding SGOT SGPT great three time normal ) , hypotension hypertension , current cardiac condition , high risk cardiovascular disease , seizure disorder , another significant underlying medical condition would contraindicate Doxazosin treatment ( 3 ) Lifetime schizophrenia , bipolar disorder , psychotic disorder ( 4 ) Actively consider plan suicidality homicidality ( 5 ) Current use prescribe psychotropic medication discontinue ( 6 ) Women plan become pregnant breastfeed study , refuse use reliable form birth control refuse monthly pregnancy test ( 7 ) Subjects prescribe antihypertension drug , except thiazide , exclude medication may interact Doxazosin 's brain effect reduce cocaine abuse .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Cocaine Dependence</keyword>
	<keyword>Substance Related Disorders</keyword>
	<keyword>genotype</keyword>
</DOC>